End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.73 CNY | +1.57% | -7.04% | -16.75% |
Mar. 18 | Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares | MT |
Mar. 05 | Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares | MT |
Business Summary
Number of employees: 39,499
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Retail
90.6
%
| 15,285 | 91.2 % | 19,242 | 90.6 % | +25.89% |
Franchise and Distribution
7.2
%
| 1,007 | 6.0 % | 1,539 | 7.2 % | +52.79% |
Other
2.2
%
| 468 | 2.8 % | 468 | 2.2 % | -0.02% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 16,759 | 100.0 % | 21,248 | 100.0 % | +26.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guo Qiang Ke
CEO | Chief Executive Officer | 42 | - |
Guang Zhi Peng
DFI | Director of Finance/CFO | 42 | 18-05-09 |
Zhi Hui Chen
CHM | Chairman | 46 | 15-05-27 |
Wen Sheng Chen
BRD | Director/Board Member | 43 | - |
Guo Zhen Chen
IRC | Investor Relations Contact | - | - |
Run Shi Liang
SEC | Corporate Secretary | 31 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Chang Liu
BRD | Director/Board Member | 61 | 16-08-07 |
Yun Feng Ke
FOU | Founder | 57 | 99-02-11 |
Zhi Hui Chen
CHM | Chairman | 46 | 15-05-27 |
Zu Yao Su
BRD | Director/Board Member | 61 | 19-11-19 |
Jie Li
BRD | Director/Board Member | 58 | 19-11-19 |
Li Ping Lu
BRD | Director/Board Member | 51 | 19-11-19 |
Wen Sheng Chen
BRD | Director/Board Member | 43 | - |
Jin Shu Shi
BRD | Director/Board Member | 38 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,141,539,331 | 380,849,769 ( 33.36 %) | 2,693,579 ( 0.2360 %) | 33.36 % |
Company contact information
DaShenLin Pharmaceutical Group Co., Ltd.
No. 410, No. 410-1 Longxi Avenue Liwan District
510000, Guangzhou
+86 20 8128 4688
http://www.dslyy.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.75% | 3.26B | |
-32.59% | 15.18B | |
-31.97% | 10.1B | |
+9.54% | 6.12B | |
-11.41% | 5.97B | |
-30.42% | 5.65B | |
-0.88% | 4.71B | |
+51.58% | 4.26B | |
-12.22% | 3.58B | |
-6.93% | 3.07B |
- Stock Market
- Equities
- 603233 Stock
- Company DaShenLin Pharmaceutical Group Co., Ltd.